期刊文献+

雌激素联用宫缩剂对宫缩乏力性产后出血疗效及安全性分析 被引量:2

Efficacy and safety of estrogen combined with oxytocin in treatment of postpartum hemorrhage due to uterine atony
下载PDF
导出
摘要 目的探讨雌激素联用宫缩剂对宫缩乏力性产后出血疗效及安全性分析。方法将2016年2月~2019年2月在妇产科治疗的80例宫缩乏力性产后出血患者随机分为两组,对照组单用缩宫素治疗,观察组给予雌激素与宫缩剂联用,比较两组患者的临床疗效、产后出血量、预后、不良反应。结果观察组治疗总有效率为95%,明显高于对照组的70%(P<0.05);观察组治疗后2h内出血量、2~24h内出血量明显少于对照组(P<0.05);观察组子宫切除率、死亡率明显低于对照组(P<0.05);观察组恶心呕吐、头痛、胸闷、乳房胀痛等不良反应发生率明显低于对照组(P<0.05)。结论雌激素联用宫缩剂对宫缩乏力性产后出血疗效显著,能有效增强子宫收缩,减少产后出血量,改善预后,且不良反应发生率低,具有较高的有效性及安全性。 Objective To investigate the efficacy and safety of estrogen combined with oxytocin in the treatment of postpartum hemorrhage due to uterine atony.Methods 80 cases of postpartum hemorrhage due to uterine inertia were randomly divided into two groups from February 2016 to February 2019.The control group was treated with oxytocin alone,while the observation group was treated with estrogen combined with uterine contraction agents.The clinical efficacy,postpartum hemorrhage volume,prognosis and adverse reactions of the two groups were compared.Results The effective rate of the observation group was 95%,which was significantly higher than 70%of the control group(P<0.05);the amount of bleeding within 2 hours and 2~24 hours after treatment in the observation group was significantly less than that in the control group(P<0.05);the rate of hysterectomy and mortality in the observation group were significantly lower than those in the control group(P<0.05);the incidence of adverse reactions such as nausea,vomiting,headache,chest distress and breast distention in the observation group was significantly lower(P<0.05).Conclusion The combination of estrogen and uterine contraction agent has a significant effect on postpartum hemorrhage caused by uterine inertia.It can effectively enhance uterine contraction,reduce postpartum hemorrhage and improve prognosis.The incidence of adverse reactions is low,and it has high effectiveness and safety.
作者 李梅 唐艳青 LI Mei;TANG Yan-qing(Department of Obstetrics,Bengbu First People's Hospital,Anhui,Bengbu 233000,China)
出处 《中国处方药》 2019年第9期115-117,共3页 Journal of China Prescription Drug
关键词 宫缩乏力性产后出血 雌激素 宫缩剂 疗效 安全性 Uterine atony postpartum hemorrhage Estrogen Uterine contraction agent Therapeutic effect Safety
  • 相关文献

参考文献9

二级参考文献49

  • 1全国产后出血防治协作组.中国妇女产时及产后24小时内失血量调查[J].中华妇产科杂志,1987,22(6):316-316.
  • 2黄智凤.高危妊娠[M].北京:人民军医出版社,2003:484.
  • 3BERG CJ, CALLAGHAN WM, SYVERSONC, et al. Pregnancy - related mortality in the United States, 1985 to 2005 [ J]. Obstet Gynecol,2010,116(6) :1302 - 1309.
  • 4苏应宽,徐增祥,江森.实用妇产科学[M].济南:山东科学技术出版社,2004:487.
  • 5Cunningham FG. Williams obstetrics[M]. 21th, ed., Stamford CT:Appelton and Lange, 2002: 638-9.
  • 6Klein M, Gauthier RC, Jorgensen SH, et al. Does episiotomy prevent perineal trauma and plevic floor relaxation? the first North American randomized controlled trial of episiotomy [J/OL]. the on-line journal of current clinical trials. American Association for the Advancement of Science, 1992.
  • 7Hendricks CH, Brenner WE. Cardiovascular effects ofoxytocin drugs used postpartum [J]. Am J Obstet Gynecol, 1970, 108:751-60.
  • 8de Chemey AH, Nathan L, Current Obstetric & Gyencologic Diagnosis & Treatment[M]. 北京:人民卫生出版社, 2003: 141.
  • 9吴丽萍.欣母沛用于难治性宫缩乏力性产后出血的临床观察和护理[J].实用临床医药杂志(护理版),2009,5(1):64-65. 被引量:64
  • 10卢红.产后出血患者的危险因素分析与预防研究[J].临床医学工程,2010,17(3):61-62. 被引量:4

共引文献35

同被引文献41

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部